A detailed history of Comerica Bank transactions in Insmed Inc stock. As of the latest transaction made, Comerica Bank holds 62,094 shares of INSM stock, worth $4.59 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares
62,094
Previous 53,775 15.47%
Holding current value
$4.59 Million
Previous $3.6 Million 25.82%
% of portfolio
0.02%
Previous 0.02%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$62.0 - $79.01 $515,778 - $657,284
8,319 Added 15.47%
62,094 $4.53 Million
Q2 2024

Aug 15, 2024

BUY
$22.0 - $69.71 $93,170 - $295,221
4,235 Added 8.55%
53,775 $3.6 Million
Q1 2024

May 15, 2024

BUY
$25.72 - $29.94 $1.24 Million - $1.45 Million
48,327 Added 3984.09%
49,540 $1.34 Million
Q4 2023

Feb 14, 2024

SELL
$23.42 - $31.74 $444 - $603
-19 Reduced 1.54%
1,213 $37,000
Q3 2023

Nov 21, 2023

BUY
$19.86 - $26.93 $24,467 - $33,177
1,232 New
1,232 $31,000

Others Institutions Holding INSM

About INSMED Inc


  • Ticker INSM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 135,476,992
  • Market Cap $10B
  • Description
  • Insmed Incorporated, a biopharmaceutical company, develops and commercializes therapies for patients with serious and rare diseases. The company offers ARIKAYCE for the treatment of Mycobacterium avium complex lung disease as part of a combination antibacterial drug regimen for adult patients. It is also developing Brensocatib, an oral reversibl...
More about INSM
Track This Portfolio

Track Comerica Bank Portfolio

Follow Comerica Bank and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Comerica Bank, based on Form 13F filings with the SEC.

News

Stay updated on Comerica Bank with notifications on news.